Merck

Welcome to the 'Merck' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Merck'.

Latest blogosphere posts tagged “Merck”

• S.E.C. Said to Eye Insider Trading in Healthcare Deals

  
  DealBook — Authority: 767
  A new U.S. securities regulatory investigation into potential insider trading began in mid-November with the issuance of subpoenas to a number of hedge funds that may have gotten an advance word on corporate takeovers, according to press reports.
  3 hours ago

• FAES Farma, S.A. Signs Agreement With Merck & Co., Incs Subsidiary For Commercialization Of Etoricoxib Drug

  
  Pharmainfo.net — Authority: 172
  FAES Farma, S.A. Signs Agreement With Merck & Co., Incs Subsidiary For Commercialization Of Etoricoxib Drug Reuters Key Development - 15 hours ago Advertisement: read more
  4 hours ago

• Genzyme Elects Robert Bertolini to Its Board

  
  Pharmainfo.net — Authority: 172
  Genzyme Elects Robert Bertolini to Its Board Trading Markets - 27 minutes ago Dec 11, 2009 (Close-Up Media via COMTEX) -- MRK -- Genzyme Corp. has announced the election of Robert J. Bertolini to the companys board of directors. Bertolini was executive vice president and ... Advertisement: read more
  7 hours ago

• EMD Chemicals Names President

  
  Pharmainfo.net — Authority: 172
  EMD Chemicals Names President Trading Markets - 20 minutes ago Dec 11, 2009 (Close-Up Media via COMTEX) -- MRK -- Deon Vos has been named President and Managing Director of EMD Chemicals. He succeeds Meiken Krebs, who will assume the position of Senior Vice ... Advertisement: read more
  7 hours ago

• Senate proposal would block drugmakers from using prescription records to pitch doctors

  
  Pharmainfo.net — Authority: 172
  Senate proposal would block drugmakers from using prescription records to pitch doctors Advertisement: read more
  13 hours ago

• False Populism, Real Profits for Rep. Jan Schakowsky (D-IL)

  
  Big Government — Authority: 815
  The third step in Robert Creamer’s  ten-step plan for imposing universal health care on America, according to his prison memoir, is to attack the private insurance industry: “Our messaging program over the next two years should focus heavily on reducing the credibility of the health insurance industry and ...
  17 hours ago

• Oncothyreon shares rise as partner Merck KGaA starts new late-stage study on Stimuvax

  
  Pharmainfo.net — Authority: 172
  Oncothyreon shares rise as partner Merck KGaA starts new late-stage study on Stimuvax KFSM - 6 minutes ago By AP NEW YORK (AP) — Shares of Oncothyreon Inc. rose Thursday after the company said its partner Merck KGaA started a late-stage study on Stimuvax as a potential lung cancer treatment. The stock ... ...
  20 hours ago

• Eli Lilly Ups 2010 Earnings Forecast

  
  Pharmainfo.net — Authority: 172
  Eli Lilly Ups 2010 Earnings Forecast FOXBusiness - 28 minutes ago By Ken Sweet Drug maker Eli Lilly (LLY) raised its 2010 earnings forecast as the company expects its upcoming pipeline of drugs to offset expiration of several drug patents. The company said it ... Advertisement: read more
  20 hours ago

• Oncothyreon Partner Starts New Lung Cancer Trial, Prompts Takeover Scuttle

  
  Xconomy — Authority: 672
  Biotech , cancer , vaccines Luke Timmerman wrote: Seattle-based Oncothyreon (NASDAQ: ONTY ), the developer of a vaccine treatment to stimulate the immune system against cancer cells, said today that its partner has started another pivotal trial of the product. Germany-based Merck KGaA has begun a ...
  22 hours ago

• Cure for Alzheimer’s Triggers a Nanotech Breakthrough- the Self-Cleansing Solar Panels

  
  Trends Updates — Authority: 579
  Accidental discoveries are not new to the scientific community. To prove this fact time and again, the researchers at Tel Aviv University who started out to find a cure to Alzheimer’s flipped on to a new revolution in the field of nanotechnology that might just mean better solar power. With the newly invented ...
  1 day ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 554
  Rise and shine, everyone. Another day awaits. And a busy one is predicted. We will be attending a lengthy meeting ourselves, in fact. While you ponder your own schedules and what-not, here are a few items to help you get started. Hope the day is pleasant and productive…. SEC Probes Drug Mergers For Insider Trading ...
  1 day ago

• SEC Probes Transactions In a Hunt for Inside Trades

  
  Pharmainfo.net — Authority: 172
  SEC Probes Transactions In a Hunt for Inside Trades Advertisement: read more
  1 day ago

• Missing in action: An FDA plan for postmarket drug safety

  
  DailyFinance — Authority: 782
  Filed under: Healthcare , Pfizer , Merck , GlaxoSmithKline "There have been long-standing concerns regarding the Food and Drug Administrations (FDA) oversight of postmarket drug safety." So begins a Government Accountability Office (GOA) report released on Wednesday that examines the steps the FDA has taken ...
  1 day ago

• FDA Has Failed To Make Safety Changes: GAO

  
  Pharmalot — Authority: 554
  In 2004, Merck withdrew its Vioxx painkiller, prompting intense scrutinty of the FDA’s review process. But the agency has not yet restructured its staff to better monitor drug safety, even though experts recommended several key changes back in 2006, the Associated Press reports. Although FDA officials have made ...
  2 days ago

• Bertolini Named To Genzyme Board

  
  Pharmainfo.net — Authority: 172
  Bertolini Named To Genzyme Board Trading Markets - 35 minutes ago December 9, 2009 (FinancialWire) -- Genzyme Corp. (NASDAQ: GENZ) has named Robert J. Bertolini to the companys board. Bertolini was executive vice president and chief financial officer at ... Advertisement: read more
  2 days ago

• (SNTS) Santarus FDA Approvals are on a Roll

  
  Stock Blog Hub — Authority: 459
  With two back-to-back U.S. Food and Drug Administration (FDA) approvals in its kitty, Santarus Inc. ( SNTS ) is on a roll. The company recently received approval for its over-the-counter (OTC) as well as tablet versions of flagship product, Zegerid. Zegerid is Santarus’ lead product which accounted for ...
  2 days ago

• Comtex SmarTrend(R) Morning Call -- December 8, 2009

  
  Pharmainfo.net — Authority: 172
  Comtex SmarTrend(R) Morning Call -- December 8, 2009 Trading Markets - 53 minutes ago Dec 08, 2009 (SmarTrend via COMTEX) -- VZ -- In a speech yesterday the Fed Chairman succeeded in switching investor concern from a potential rise in interest rates anytime soon, back to worrying ... Advertisement: read more
  2 days ago

• PhillyDeals: Solazyme gets grant for biorefinery project in Pa. | Philadelphia Inquirer | 12/08/2009

  
  Pharmainfo.net — Authority: 172
  PhillyDeals: Solazyme gets grant for biorefinery project in Pa. | Philadelphia Inquirer | 12/08/2009 Advertisement: read more
  3 days ago

• Addex Extends Parkinsons Disease Collaboration with Merck & Co., Inc.

  
  Pharmainfo.net — Authority: 172
  Addex Extends Parkinsons Disease Collaboration with Merck & Co., Inc. Advertisement: read more
  4 days ago

• Top Dividend Stocks to Consider Now (NYSE: JNJ),(NYSE: CVX),(NYSE: MRK)

  
  Pharmainfo.net — Authority: 172
  Top Dividend Stocks to Consider Now (NYSE: JNJ),(NYSE: CVX),(NYSE: MRK) WallStNation.com - 8 minutes ago Sometimes you are just looking for a good dividend stock of a solid company to get your portfolio stabilized a bit. We present to you Johnson & Johnson (NYSE:JNJ), Chevron Corporation (NYSE:CVX ... ...
  5 days ago

Comments about Merck